The chief executive of Germany's BioNTech SE said the biggest challenge facing it and partner Pfizer Inc now that their COVID-19 vaccine is authorized for use in the United States will be to scale up...
from NDTV News - Latest https://ift.tt/37aOmwf
No comments:
Post a Comment